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Abstract
There are several studies in which a correlation between maternal vitamin D deficiency and serum mineral disorders in the mother and
the newborn has been reported. The present randomised clinical trial was designed to investigate the effect of vitamin D administration
on maternal and fetal Ca and vitamin D status. The trial was carried out on 160 pregnant women. Vitamin D-deficient (25-hydroxyvitamin D
(25(OH)D) ,30 ng/ml) pregnant women were recruited at 26–28 weeks of pregnancy. In the control group, a multivitamin supplement
containing 400 IU vitamin D3/d was given. Patients in the treatment group were treated with 50 000 IU vitamin D3 weekly for a total
duration of 8 weeks. At delivery, maternal and fetal Ca and 25(OH)D levels in both groups were compared. In total, 81 % of pregnant
women were vitamin D deficient. At the time of delivery, Ca and vitamin D levels were higher in the treatment group compared with
the control group (92 (SD 3) v. 85 (SD 4) mg/l, respectively, P¼0·001 for serum Ca; 47·8 (SD 11·1) v. 15·9 (SD 6·6) ng/ml, respectively,
P,0·001 for vitamin D). At the time of delivery, 32·7 % of women in the control group had hypocalcaemia, while no hypocalcaemic
case was detected in the vitamin D-treated group. Mean neonatal serum 25(OH)D was higher in the treatment group compared with
the control group (27·7 (SD 5·2) v.10·9 (SD 4·4) ng/ml, respectively, P,0·01). The neonatal Ca level in the treatment group was significantly
higher than that of the control group (99 (SD 3) v. 91 (SD 3) mg/l, respectively, P,0·001). The administration of vitamin D to pregnant
women with vitamin D deficiency improves both maternal and neonatal Ca levels.
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Vitamin D is an essential substance for maintaining the
natural bone architecture. Vitamin D deficiency can lead
to complications including osteomalacia and secondary osteo-
porosis(1). During pregnancy, considerable amounts of Ca are
transferred from the mother to the fetus, and the preparation
of such supply of Ca is mainly achieved by the regulation
of increased intestinal Ca absorption. Moreover, during
pregnancy, the concentration of 1,25-dihydroxyvitamin D
increases two to three times above the normal range mainly
because of the increase in renal 1-a-hydroxylase activity(2).
Theoretically, vitamin D deficiency in mothers could lead
to a low production of 1,25-dihydroxyvitamin D due to
substrate reduction. Maternal 1,25-dihydroxyvitamin D is
transported to the fetus through the placenta, and the cord
blood vitamin D level is equal to or at most 25 % lower than
the maternal concentration(3).
There are only a few foods that are good sources of
vitamin D, and in countries with no food fortification indus-
tries, the generation of vitamin D in the skin is the major
source of vitamin D in the body. However, many studies
have reported high frequencies of vitamin D deficiency in
sunny countries(4–7).
Vitamin D deficiency is highly common in Iran, and based
on several reports, up to 80 % of women living in Tehran
suffer from mild to severe vitamin D deficiency(8). Studies
on pregnant women have also shown a high prevalence of
vitamin D deficiency, particularly in developing countries
including Iran(9–13). Maternal vitamin D deficiency has several
disadvantages to fetal outcomes. In cross-sectional studies, a
correlation of maternal 25-hydroxyvitamin D (25(OH)D)
levels with fetal femur volume(14) and newborn weight(15)
has been reported.
*Corresponding author: Dr F. Lalooha, fax þ98 281 3326033, email mdrc46@yahoo.com
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There are limited clinical trials investigating the effect of
vitamin D therapy in the mother on the serum mineral status
of both the mother and the newborn. In some studies, an
improvement in serum Ca concentrations of the mother as
well as a reduced possibility of neonatal hypocalcaemia
have been reported(16,17). In these studies, different doses of
vitamin D were used regardless of the mother’s initial vitamin
D level. The present randomised clinical trial was conducted
to investigate the effect of vitamin D administration in preg-
nant women with vitamin D deficiency on maternal and
fetal 25(OH)D and Ca levels.
Materials and methods
This was an open-label, randomised clinical trial carried out in
Qazvin (Iran) during December 2011 to March 2012. The pri-
mary outcome was to evaluate the effect of treating maternal
vitamin D deficiency on newborn vitamin D status. Additional
analyses were performed to evaluate the effect on maternal
and newborn hypocalcaemia (as secondary outcomes).
A total of 160 pregnant women at their twenty-four to
twenty-six gestational weeks, who were referred for prenatal
care to an obstetric clinic, were investigated. Inclusion criteria
included a gestational age of 24–26 weeks, singleton preg-
nancy and a BMI of 19–26 kg/m2. Exclusion criteria were
gestational diabetes or diabetes before pregnancy, severe
pre-eclampsia, chronic hypertension, fetal anomaly,
oligohydramnios or polyhydramnios, a history of repeated
abortion, rheumatoid arthritis, parathyroid disorders, hepatic
or renal diseases, preterm delivery (before week 37), and use
of aspirin, anti-convulsive and immunosuppressive drugs.
Initially, blood samples were collected from pregnant women
for the measurement of serum vitamin D levels, and once the
results were obtained, those with vitamin D deficiency entered
the study. Vitamin D deficiency was defined as serum
25(OH)D less than 30 ng/ml. Participants were randomly
160 Eligible subjects
25(OH)D assesment
Thirty subjects with
25(OH)D >30 ng/ml
were excluded
Randomisation
Sixty-five subjects in
the control group
Loss of eleven subjects
(one due to GDM, ten
difficult to access due to
delivery in other places)
Fifty-four pregnant women
and fifty-four neonates for
final analysis
Fifty-five pregnant women
and fifty-five neonates for
final analysis
Loss of ten subjects
(one due to PROM, nine
difficult to access due to
delivery in other places)
Sixty-five subjects in the
treatment group
Fig. 1. CONSORT (Consolidated Standards of Reporting Trials) flow chart of the study. 25(OH)D, 25-hydroxyvitamin D; PROM, premature rupture of the
membrane; GDM, gestational diabetes mellitus.
Table 1. Baseline demographic and reproductive variables of the treat-
ment and control subjects who completed the study
(Mean values and standard deviations)
Control
group
Treatment
group
Mean SD Mean SD
n (after randomisation) 65 65
n (completed the study) 54 55
Age (years) 27·62 4·63 25·05 4·62
BMI (kg/m2) 24·43 2·53 24·24 2·58
Sunlight exposure time (min/d) 35·64 6·1 36·39 5·9
Women using chador (%) 25·9 21·8
Gestational age at delivery (weeks) 38·5 0·11 38·5 0·11
Vitamin D level (ng/ml) 17·5 4·8 15·8 5·6
Median vitamin D level (ng/ml) 18·00 16·70
Ca level (mg/l) 84 3·9 85 4·2
Median Ca level (mg/l) 84 86
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assigned to two treatment and control groups using a compu-
terised random number generator. Enrolment was performed
by obstetrician who was responsible for prenatal care. The pre-
sent study was conducted according to the guidelines laid down
in the Declaration of Helsinki, and all procedures involving
human subjects were approved by the Ethics Committee of
Qazvin University of Medical Science. Written informed consent
was obtained from all subjects. The control group received a
multivitamin containing 400 IU vitamin D3 plus 200 mg elemen-
tal Ca daily until the end of pregnancy. Subjects in the treatment
group received a weekly dose of 50 000 IU vitamin D3 for
8 weeks (from 26 to 28 weeks of pregnancy) as well as the
drug regimen given to the control group. Participants visited
once every 2 weeks during the second trimester and once
per week within the third trimester, and parameters such as
weight, blood pressure, uterine fundal height and use of the
vitamin D supplement and multivitamin were followed up.
Following delivery, blood samples (5 ml) from the mother and
the umbilical cord were taken after clamping and sent to the
hospital laboratory to be centrifuged and kept frozen until use.
The Ca level was determined by calorimetry using a commercial
kit (Zist-Shimi). Serum Ca less than 83 mg/l was defined as
hypocalcaemia. The intra-assay and inter-assay for Ca measure-
ments were 2·3 and 2·6 %, respectively. Serum vitamin D
was determined by an ELISA reader (Awareness Technology)
and a commercial kit (Euroimmun). The intra-assay and inter-
assay for 25(OH)D were 3·3 and 6·7 %, respectively. Serum
25(OH)D ,30 ng/ml was considered as vitamin D deficiency.
An additional analysis was performed on the cut-off of
25(OH)D,10 ng/ml as more sever vitamin D deficiency.
Data are presented as frequency distribution tables and
numeric indices. Vitamin D status was presented as frequency
distribution tables and numeric indices. ANCOVA was used
to compare maternal serum vitamin D and Ca at delivery
between the two groups. A x 2 test was used for comparing
the frequency of vitamin D deficiency and hypocalcaemia
between the two groups. For analysing serum vitamin D and
Ca levels after the intervention compared with the pretreat-
ment level in pregnant women, a paired t test was used. To
examine the presence of any possible correlation, Pearson’s
correlation coefficient was employed.
Results
Of the 160 pregnant women (81 %), 130 had vitamin D
deficiency. During the study, twenty-one pregnant women
were excluded: one with gestational diabetes (in control
group); one with a premature rupture of the membrane in
the treatment group; ten in the control group and nine in
the treatment group had difficulty to access due to their deliv-
ery in other places (Fig. 1). Complete results were obtained
from fifty-four subjects in the control group and fifty-five
subjects in the treatment group, and statistical analysis was
performed on their baseline and outcome data. Mean gravid-
ity, gestational age at delivery, sun exposure time and serum
vitamin D and Ca levels were not significantly different
between the two groups (Table 1). T
a
b
le
2
.
C
o
m
p
a
ri
s
o
n
o
f
m
a
te
rn
a
l
a
n
d
n
e
o
n
a
ta
l
v
it
a
m
in
D
a
n
d
c
a
lc
iu
m
le
v
e
ls
in
th
e
tw
o
g
ro
u
p
s
fo
llo
w
in
g
th
e
in
te
rv
e
n
ti
o
n
(M
e
a
n
v
a
lu
e
s
,
s
ta
n
d
a
rd
d
e
v
ia
ti
o
n
s
a
n
d
9
5
%
c
o
n
fi
d
e
n
c
e
in
te
rv
a
ls
)
P
re
g
n
a
n
t
w
o
m
e
n
N
e
w
b
o
rn
s
C
o
n
tr
o
l
T
re
a
tm
e
n
t
C
o
n
tr
o
l
T
re
a
tm
e
n
t
M
e
a
n
S
D
9
5
%
C
I
M
e
a
n
S
D
9
5
%
C
I
M
e
a
n
S
D
9
5
%
C
I
M
e
a
n
S
D
9
5
%
C
I
n
5
4
5
5
5
4
5
5
V
it
a
m
in
D
le
v
e
l
(n
g
/m
l)
1
5
·9
6
·6
1
4
·1
,
1
7
·8
4
7
·8
*†
1
1
·1
4
4
·8
,
5
0
·8
1
0
·9
4
·4
9
·4
,
1
1
·9
2
7
·7
**
‡
5
·2
2
6
·3
,
2
9
·1
2
5
(O
H
)D
,
1
0
n
g
/m
l
(%
)
2
2
·2
1
1
·1
,
3
2
·2
0
*§
5
0
·9
3
7
·7
,
6
4
·1
0
*§
1
0
n
g
/m
l#
2
5
(O
H
)D
,
3
0
n
g
/m
l
(%
)
7
4
·1
6
2
·4
,
8
5
·7
0
*§
4
9
·1
3
5
·9
,
6
2
·3
6
7
·3
(N
S
)§
5
5
,
7
9
·6
V
it
a
m
in
2
5
(O
H
)D
$
3
0
n
g
/m
l
(%
)
3
·7
0
,
8
·7
1
0
0
*§
0
3
2
·7
*§
2
0
·4
,
4
5
·0
C
a
le
v
e
l
(m
g
/l
)
8
5
4
8
4
,
8
7
9
2
*†
3
9
1
,
9
3
9
1
3
9
0
,
9
2
9
9
**
‡
3
9
8
,
1
0
0
H
y
p
o
c
a
lc
a
e
m
ia
(C
a
,
8
3
m
g
/l
)
3
2
·7
2
0
·2
,
4
5
·2
0
*§
3
·7
0
,
8
·7
0
(N
S
)§
2
5
(O
H
)D
,
2
5
-h
y
d
ro
x
y
v
it
a
m
in
D
.
M
e
a
n
v
a
lu
e
s
w
e
re
s
ig
n
ifi
c
a
n
tl
y
d
if
fe
re
n
t
c
o
m
p
a
re
d
w
it
h
th
e
c
o
n
tr
o
l
g
ro
u
p
:
*
P
,
0
·0
0
0
1
,
**
P
,
0
·0
1
.
†
A
N
C
O
V
A
te
s
t.
‡
t
te
s
t.
§
x
2
te
s
t.
Vitamin D therapy and mineral status 1613
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
Maternal vitamin D and calcium levels
The mean vitamin D level before the intervention was 17·5
(SD 4·8) ng/ml in the control group and 15·8 (SD 5·6) ng/ml
in the treatment group (Table 1). At the time of delivery, the
serum vitamin D level was significantly higher in the treatment
group compared with the control group, with a mean differ-
ence of 31·8 (95 % CI 28·3, 35·3) ng/ml (ANCOVA test,
P¼0·0001; Table 2). In the control group, the mean serum
25(OH)D concentration at the end of the study was even
lower than the pre-intervention concentration (21·6 ng/ml,
paired t test P,0·05), while mean serum 25(OH)D was
31·97 ng/ml higher than the pretreatment level in the treat-
ment group. (P,0·0001, paired t test).
Moreover, the serum concentration of vitamin D in all the
vitamin D-treated pregnant women (100 %) was higher than
30 ng/ml at the time of delivery, while in the control group,
only two women (3·7 %) had a vitamin D level .30 ng/ml
(P,0·0001). The frequency of serum vitamin D ,10 ng/ml
in the control group was 22·2 (95 % CI 11·1, 33·2) % at the
end of the study (P,0·0001; Table 2).
Serum Ca concentration was significantly higher in the treat-
ment group at the time of delivery than in the control group,
as shown in Table 2 (P¼0·001). Before the intervention, hypo-
calcaemia was present in 32·7 and 29 % of the subjects in
the control and treatment groups, respectively. The frequency
of hypocalcaemia (Ca ,83 mg/l) was 32·7 (95 % CI 20·4,
45·0) % in the control group, whereas hypocalcaemia was
not found in the treatment group (P¼0·0001; Fig. 2). All of
the hypocalcaemic subjects before and after the intervention
were asymptomatic. None of the subjects had sever hypo-
calcaemia (Ca ,75 mg/l).
Neonatal vitamin D and calcium levels
As shown in Table 2, the mean vitamin D level in the serum
sample, obtained from the umbilical cord, was significantly
higher in the treatment group compared with the control group
(27·7 (SD 5·2) v. 10·9 (SD 4·4) ng/ml, respectively, P¼0·001). All
newborns in the control group were vitamin D deficient
(25(OH)D ,30ng/ml), while the frequency of vitamin D
deficiency in the treatment group was 67·3 (95% CI 55·0, 79·6)%.
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Fig. 2. (a) Scatter plot of serum 25-hydroxyvitamin D (25(OH)D) of pregnant women in the two control and treatment groups before and after the intervention.
(Upper), diagnostic cut-off of vitamin D deficiency (25(OH)D ,30 ng/ml); (lower), cut-off of more sever hypovitaminosis D (25(OH)D ,10 ng/ml). (b) Scatter
plot of serum calcium of pregnant women in the two control and treatment groups before and after the intervention. (Lower) and (upper) (83 and 105 mg/l)
represent the lower and upper limits of the normal range for serum calcium, respectively.
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Fig. 3. (a) Scatter plot of serum calcium of newborns in the two control and treatment groups. (Lower) and (upper) (83 and 105 mg/l) represent the
lower and upper limits of the normal range for serum calcium, respectively. (b) Scatter plot of serum 25-hydroxyvitamin D (25(OH)D) of newborns in the two
control and treatment groups. (Upper), diagnostic cut-off of vitamin D deficiency (25(OH)D ,30 ng/ml); (lower), cut-off of more sever hypovitaminosis D
(25(OH)D ,10 ng/ml). (A colour version of this figure can be found online at http://www.journals.cambridge.org/bjn).
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The frequency of serum 25(OH)D ,10 ng/ml was 50·9
(95 % CI 37·7, 64·1) % in the newborns of the control group.
None of the newborns in the treatment group had 25(OH)D
,10 ng/ml (P,0·0001; Table 2).
The Ca level in blood samples taken from the umbilical
cord was significantly higher in the treatment group than
that found in the control group, as shown in Table 2 (mean
difference: 7·8 (95 % CI 0·63, 9) mg/l, P¼0·0001) and Fig. 3.
There were two cases with mild hypocalcaemia in the control
group; however, the frequency of hypocalcaemia incidence
between the two groups was statistically insignificant.
There was a direct correlation between the neonatal vitamin
D levels of both groups and the maternal vitamin D level (r 0·7,
P¼0·001 for the treatment group; r 0·49, P¼0·001 for the con-
trol group; Table 3). No significant correlation was found
between the neonatal Ca level and maternal vitamin D.
Discussion
In the present study, 81 % of women at 24–28 weeks of preg-
nancy were vitamin D deficient. After 8 weeks of treatment
with vitamin D, mean maternal and neonatal vitamin D and
Ca levels were significantly higher in the treatment group
compared with the control group. At the end of the study, a
high frequency of vitamin D deficiency (96 %) and hypocal-
caemia (32 %) was detected in the pregnant women of the
control group, despite using 400 IU vitamin D3/d. There was
a strong and direct correlation between the maternal and
umbilical cord 25(OH)D levels at the time of delivery.
Several studies performed in Iran and other countries have
also indicated a high prevalence of vitamin D deficiency among
pregnant women. However, the results are conflicting for the
prevalence of vitamin D deficiency among Iranian pregnant
women, ranging from 48% in one study to 86% in another
study(12,13). Seasonal difference (sampling in the winter or
summer) and geographic variation (distance from the sea level)
are considered as important factors affecting the reported pre-
valence of vitamin D deficiency among Iranian pregnant women.
In studies reported from other Asian countries, vitamin D
deficiency has also been found to be common in pregnant
women(9–11). Vitamin D deficiency among Asian pregnant
women is a function of the overall status of vitamin D in these
societies. A high prevalence of vitamin D insufficiency has
been recognised as a clinical problem in Asian countries for
many years. A lack of food enrichment with vitamin D, genetic
factors and cultural and nutritional habits are essential factors
associated with vitamin D deficiency in Asian people(18–20).
In the present study, there was a high frequency of hypocal-
caemia in the control group, but no hypocalcaemia observed
in subjects of the vitamin D-treated group. Generally, hypoal-
bominaemia due to high intravascular volume is considered as
the major cause of mild hypocalcaemia in pregnancy(21). In
the present study, serum albumin levels were not measured
and serum Ca was not corrected for serum albumin. However,
an interesting finding was the absence of hypocalcaemic
patients in the treatment group, despite a prevalence of 29 %
in the treatment group before the intervention and a continu-
ous high prevalence of hypocalcaemia in the control group at
the end of the study. These results suggest that in the cases of
gestational hypocalcaemia, even a mild one, a high possibility
of vitamin D deficiency must be considered before attributing
the condition to the pregnancy-related dilution of albumin.
The effect of maternal vitamin D deficiency during pregnancy
on neonates has been the focus of several studies. In the present
study and in the majority of other studies, a strong and direct
correlation between the maternal and umbilical cord vitamin D
levels has been documented(22–25). A strong correlation
between the maternal and fetal vitamin D concentrations is pre-
dictable, as 25(OH)D in the mother’s serum has the ability to
easily pass through the placenta into the blood circulation of
the fetus(3). In the present study, relative and absolute vitamin
D deficiency was considerably higher among the neonates
of the control group, compared with the control group, and
in the treatment group, only one infant was found to have
absolute vitamin D deficiency (25(OH)D ,20 ng/ml).
In different studies, complications such as the increased risk
of infection(26), neonatal hypocalcaemia(27), softening of the
skull bone (craniotabes)(28) and decreased growth indices in
vitamin D-deficient infants(29,30) have been reported. In the
present study, there was no significant difference in the fre-
quency of neonatal hypocalcaemia in the control and treatment
groups; however, hypocalcaemic cases were not frequent and
were limited to only two infants in the control group.
In brief, vitamin D deficiency in pregnant women was con-
siderably common during the winter in the present study.
According to the recent recommendations(31), supplementation
with 400 IU vitamin D3/d does not prevent maternal hypovitami-
nosis D. Treatment of vitamin D-deficient pregnant women
improved maternal vitamin D status, prevented hypocalcaemia
of pregnancy and increased fetal vitamin D and Ca levels.
The present study has its own advantages and limitations.
The advantages were the randomised clinical design, the
season of performing the study (winter) and also the inclusion
of vitamin D-deficient pregnant women as a necessary cri-
terion to enter the study. The first limitation of the present
study was the lack of using placebo, although it does not
seem to have produced major effects on laboratory
parameters. The second drawback was due to the failure in
determining serum albumin levels and thus calculating cor-
rected Ca concentrations, which could have led to decreased
serum total Ca levels associated with the pregnancy-related
dilution of albumin. However, a considerable difference in
Table 3. Correlation between maternal and neonatal vitamin D
and calcium levels
Maternal
vitamin D level†
Maternal
Ca level
Neonatal parameters r P * r P*
Neonatal vitamin D
Control group 0·706 0·001 0·184 NS
Treatment group 0·491 0·001 0·133 NS
Neonatal Ca
Control group 0·273 NS 0·374 0·04
Treatment group 0·062 NS 0·102 NS
*P,0·05 indicates a significant association.
† Vitamin D level: serum 25-hydroxyvitamin D.
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the frequency of hypocalcaemia in the treatment group fol-
lowing vitamin D therapy compared with pretreatment status
and also with the control group demonstrates the importance
of treating vitamin D-deficient pregnant women to prevent
hypocalcaemia.
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